Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
United Therapeutics Corporation in RTP, NC seeks a Spring 2027 Co-op to contribute to regenerative medicine research, advanced imaging, cell culture, and data analysis focused on lung diseases. The role involves hands-on experiments and collaboration with experts in tissue engineering to advance novel cell- and tissue-based therapies.
Applicants must be actively enrolled in a master’s or PhD program and able to commit to on-site work at 40 hours per week for the duration of the co-op.
The job details are as follows:
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The selected Co-op will need to be onsite at the RTP, North Carolina lab for the entire duration of this co-op role, from January 2027 through June of 2027.
Some co-ops fetch coffee. This one explores the future of lung science. Join our team and spend your spring tackling meaningful research projects in regenerative medicine, working with advanced imaging, cell culture, data analysis, and tissue engineering technologies. You'll learn from experts, contribute to discoveries that matter, and gain the kind of hands‑on experience that can shape an entire scientific career.
This Spring 2027 Co-op will conduct and assist in research & development efforts to develop novel cell‑ and tissue‑based products for treating pulmonary hypertension and other lung diseases.
This role will complete a focused research project to address a question that is relevant to the development of a cell‑ or tissue‑based product for the treatment of lung disease(s). Generate data that addresses an insightful question and produce summary conclusions and report(s) to document the outcomes of experimental testing. Present data to management, team leaders, and research staff during internal review meetings, and make a final presentation of project findings.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.